Evidence map›Paper›PMID 21762366›Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2011

Epidemiology of resistant hypertension.

Pantelis A Sarafidis

Abstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Treatment-resistant hypertension assessed by home blood pressure monitoring: a new target for intervention?Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. A Practical Approach to Hypertension Management in Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2017
    Review
  13. Review
  14. Assessment of 25-Hydroxyvitamin D Levels in Patients with Resistant Hypertension.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2016
    Article
  15. Article
  16. Review
  17. Article
  18. Predicting blood pressure outcomes using single-item physician-administered measures: a retrospective pooled analysis of observational studies in Belgium.The British journal of general practice : the journal of the Royal College of General Practitioners · 2015
    Observational
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Pantelis A SarafidisSection of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. psarafidis11@yahoo.gr

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistant hypertension is an entity that has gained a lot of attention in recent years. The prevalence and prognosis of resistant hypertension have not yet been examined by proper population studies, but data from several sources suggest that this entity is not uncommon and is associated with an elevated risk of hypertensive complications. Moreover, several factors and conditions that can interfere with blood pressure control such as excess sodium intake, obesity, diabetes, older age, kidney disease, and certain identifiable causes of hypertension were shown to be common among patients with resistance to antihypertensive treatment. Importantly, the prevalence of several of these conditions has been increasing continuously during the past years, suggesting a future increase in the frequency of resistant hypertension. This article will discuss current knowledge and associated future implications relevant to the epidemiology of resistant hypertension.

Indexed as

HypertensionAntihypertensive AgentsAttitude to HealthBlood PressureBlood Pressure DeterminationDrug ResistanceEpidemiologic StudiesHumansLife StylePatient CompliancePrevalencePrognosisRisk FactorsAntihypertensive Agents

Identifiers

PMID21762366
PMCPMC8108804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.